Dolce your point about science being proven is just plain wrong. I believe MSB will be successful but to continue to say the science has been derisked, yeah maybe we can say that there are no adverse affects, but I don't believe that means the science works, because as aatisket has pointed out and I have pointed out over the years, there are good reasons why we need to go the phase 2 and 3 protocols, you cant dispute that. Just settle down a little and lets wait for phase 3 results first before we start saying things like that.
If your logic was write, this would be at $15 now.
- Forums
- ASX - By Stock
- MSB
- Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish
MSB
mesoblast limited
Add to My Watchlist
3.88%
!
$2.23
Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish, page-41
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
